EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.1.3 | Fructose Intolerance |
8471037 |
Expression of rat liver ketohexokinase in yeast results in fructose intolerance. |
ongoing research
unassigned |
2
0 |
| 2.7.1.3 | ketohexokinase deficiency |
12941785 |
Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. |
causal interaction
unassigned |
4
0 |
| 2.7.1.3 | Carcinoma |
16372272 |
The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
4
0 |
| 2.7.1.3 | Carcinoma, Renal Cell |
16372272 |
The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
4
0 |
| 2.7.1.3 | Neoplasms |
16372272 |
The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
4
0 |
| 2.7.1.3 | Hyperoxaluria |
19300989 |
Calciuria, oxaluria and phosphaturia after ingestion of glucose, xylitol and sorbitol in two population groups with different stone-risk profiles. |
causal interaction
therapeutic application
unassigned |
3
2
0 |
| 2.7.1.3 | Hepatitis |
20205309 |
Science letters: Proteomic analysis of differentially expressed proteins in mice with concanavalin A-induced hepatitis. |
unassigned |
0 |
| 2.7.1.3 | Obesity |
22795331 |
Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 2.7.1.3 | Obesity |
24900346 |
Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. |
therapeutic application
unassigned |
4
0 |
| 2.7.1.3 | Cardiomegaly |
26083752 |
HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. |
therapeutic application
unassigned |
1
0 |
